top of page
Procainamide

普魯卡因胺
Mechanism of action:
Procainamide 是一種 class IA 鈉離子通道阻斷劑(class IA sodium channel blocker)。Procainamide 會結合心肌細胞膜上的電壓門控鈉離子通道(voltage-gated Na⁺ channel),降低第 0 期(phase 0)去極化速率,使心肌傳導速度變慢,尤其影響心房、心室與浦金耶纖維(Purkinje fiber)。除了鈉離子通道阻斷外,procainamide 亦會抑制部分鉀離子外流(K⁺ currents),導致動作電位時間延長、有效不反應期延長。
Reference(s):
1. Chiu PJ et al. (2004). Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. J Pharmacol Sci.
2. Tobita M et al. (2005). A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorg Med Chem Lett.
3. Liu T et al. (2025). BindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data. Nucleic Acids Res.
bottom of page
